Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hisamitsu Pharmaceutical Co., Inc.
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of HKT-500 in the Treatment of Pain Associated With Mild to Moderate Ankle Sprain
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
mild to Moderate Ankle Sprain
You may not be if
Any women of childbearing potential who has a positive urine pregnancy test, who is lactating, who is not surgically sterile (by tubal ligation or hysterectomy), who is not at least 2 years postmenopausal, or has not practiced an acceptable form of birth control (defined as the use of an intrauterine device with spermicide, a barrier method with spermicide, condoms with spermicide, subdermal implant, oral contraceptives, or abstinence) for at least 2 months prior to Visit 1.
Clareo Health | HKT-500 in the Treatment of Adult Patients With Ankle Sprain
